Superseded · version 1: Survodutide^↗

Related names recorded in this version: BI 456906^↗

A glucagon/GLP-1 receptor agonist candidate represented in ClinicalTrials.gov.^↗

This is preserved historical wording.
It is no longer the current profile. Read the current profile and its correction notice.

What this version reported

ClinicalTrials.gov lists a Boehringer Ingelheim study as active, not recruiting, updated July 22, 2026.^↗

Organizations named in cited records:

Trial records: NCT05202353